文献速递食管与纵隔外科

食管癌患者食管切除术后患者报告结局的初步研究

Pilot Study of Patient-Reported Outcomes in Patients With Esophageal Cancer After Esophagectomy.
PubMed 文献 · Ann Thorac Surg · 2022-01-13

本研究前瞻性纳入2017至2020年接受食管切除术的112例食管癌患者,采用PROMIS评估术前及术后1、6个月的呼吸困难严重程度、躯体功能和疼痛干扰。术后1个月三项评分均显著恶化;术后6个月躯体功能和呼吸困难恢复至基线,但疼痛干扰持续较差(最小二乘均值差2.7±2.5,P=0.036)。经膈肌裂孔食管切除术患者术后1个月(最小二乘均值差6.5±5.1,P=0.013)和6个月(最小二乘均值差5.2±3.9,P=0.008)的疼痛干扰评分均持续优于经胸食管切除术患者。

要点

  • 食管切除术后1个月疼痛干扰、躯体功能和呼吸困难严重程度评分均显著恶化。
  • 术后6个月躯体功能和呼吸困难恢复至基线,但疼痛干扰持续较差(最小二乘均值差2.7±2.5,P=0.036)。
  • 经膈肌裂孔食管切除术患者术后1个月和6个月疼痛干扰评分均持续优于经胸食管切除术患者。

核心结论

  • 本初步研究显示,食管癌食管切除术后疼痛是持续报告的症状,长达术后6个月,尤其在经胸食管切除术患者中。

研究设计与样本

  • 前瞻性收集2017至2020年接受食管切除术的食管癌患者的PROMIS呼吸困难严重程度、躯体功能和疼痛干扰数据,并与本机构胸外科医师学会食管切除术数据库合并,共纳入112例患者。
  • 采用线性混合效应多变量模型评估术前与术后1个月和6个月PROMIS评分的变化(最小二乘均值差)。

主要发现

  • 术后1个月疼痛干扰、躯体功能和呼吸困难严重程度评分均显著恶化。
  • 术后6个月躯体功能和呼吸困难严重程度评分恢复至基线,但疼痛干扰评分持续较差(最小二乘均值差2.7±2.5,P=0.036)。
  • 经膈肌裂孔食管切除术与经胸食管切除术患者在各评估点的躯体功能和呼吸困难严重程度评分相似。
  • 经膈肌裂孔食管切除术患者术后1个月(最小二乘均值差6.5±5.1,P=0.013)和6个月(最小二乘均值差5.2±3.9,P=0.008)的疼痛干扰评分均持续优于经胸食管切除术患者。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patient-reported outcomes (PROs) are critical measures of patient well-being after esophagectomy. In this pilot study, we assessed PROs before and after esophagectomy using the Patient Reported Outcomes Measurement Information System (PROMIS) to assess patient recovery after surgery. METHODS: We prospectively collected PROMIS dyspnea severity, physical function, and pain interference measures from patients with esophageal cancer undergoing esophagectomy (2017-2020). We merged these data with our institutional Society of Thoracic Surgery esophagectomy database. We used linear mixed-effect multivariable models to assess changes in PROMIS scores (least square mean [LSM] differences) preoperatively and postoperatively at 1 and 6 months. RESULTS: The study included 112 patients undergoing esophagectomy. Pain interference, physical function, and dyspnea severity scores were significantly worse 1 month after surgery. While physical function and dyspnea severity scores returned to baseline 6 months after surgery, pain interference scores remained persistently worse (LSM difference, 2.7 ± 2.5; P = .036). PROMIS scores were further assessed among patients undergoing transhiatal esophagectomy compared with transthoracic esophagectomy. Physical function and dyspnea severity scores were similar between the groups at each assessment. However, pain interference scores were persistently better among patients undergoing THE at both 1 month (LSM difference, 6.5 ± 5.1; P = .013) and 6 months after surgery (LSM difference, 5.2 ± 3.9; P = .008). CONCLUSIONS: This pilot study assessing PROMIS scores after esophagectomy for cancer reveals that pain is a persistently reported symptom up to 6 months after surgery, particularly among patients receiving transthoracic esophagectomy.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Heiden BT, Subramanian MP, Liu J, et al. Pilot Study of Patient-Reported Outcomes in Patients With Esophageal Cancer After Esophagectomy. Ann Thorac Surg. 2022. PMID: 35033508. doi:10.1016/j.athoracsur.2021.12.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。